Advertisement

Liposomes as Carriers of Vaccines: Development of a Liposomal Malaria Vaccine

  • Carl R. Alving
  • Robert L. Richards
  • Michael D. Hayre
  • Wayne T. Hockmeyer
  • Robert A. Wirtz
Part of the NATO ASI Series book series (NSSA, volume 179)

Abstract

Liposomes that have been injected parenterally into animals have a well-known natural tendency to be ingested rapidly and in large amounts by macrophages. Uptake of liposomes by macrophages has often been cited as a potential hurdle that could theoretically block applications of liposomes as drug carriers for certain purposes. However, the macrophage itself has served as a target for delivery of liposome-encapsulated drugs and immunomodulators, particularly for treatment of infectious diseases and cancer (Alving, 1983, 1989; Fidler, 1985; Swenson et al, 1988). It is certainly true that overcoming of the macrophage as an “obstacle” can be difficult, but several reports have indicated that increased blood circulation time and distribution of liposomes to certain tissues can be achieved by the use of special biophysically or biochemically tailored liposomes (Hwang et al, 1980; Gregoriadis et al, 1982; Allen and Chonn, 1987; Papahadjopoulos and Gabizon, 1987; Gabizon and Papahadjopoulos, 1988).

Keywords

Plasmodium Falciparum Humoral Immune Response Plasmodium Falciparum Malaria Initial Immunization Bovine Serum Albumin Conjugate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, T.M. and Chonn, A., 1987, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS.Lett., 223: 42.PubMedCrossRefGoogle Scholar
  2. Alving, C.R., 1989, Macrophages as targets for delivery of liposomeencapsulated antimicrobial drugs, Advanced Drug Deliv. Rev. (in press).Google Scholar
  3. Alving, C.R., 1987, Liposomes as carriers of vaccines, in: “Liposomes from Biophysics to Therapeutics”, M.J. Ostro, ed., Marcel Dekker, Inc., New York.Google Scholar
  4. Alving, C.R., Richards, R.L., Moss, J., Alving, L.I., Clements, J.D., Shiba, T., Kotani, S., Wirtz, R.A. and Hockmeyer, W.T., 1986, Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite vaccine, Vaccine, 4: 166.PubMedCrossRefGoogle Scholar
  5. Alving, C.R., 1983, Delivery of liposome-encapsulated drugs to macrophages, Pharmacol.Therap., 22: 407.CrossRefGoogle Scholar
  6. Ballou, W.R., Rothbard, J., Wirtz, R.A., Gordon, D.M., Williams, J.S., Gore, R.W., Schneider, I., Hollingdale, M.R., Beaudoin, R.L., Maloy, W.L., Miller, L.H. and Hockmeyer, W.T., 1985, Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum, Science, 228: 996.PubMedCrossRefGoogle Scholar
  7. Ballou, W.R., Hoffman, S.L., Sherwood, J.A., Hollingdale, M.R., Neva, F.A., Hockmeyer, W.T., Gordon, D.M., Schneider, I., Wirtz, R.A., Young, J.F., Wasserman, CF., Reeve, P., Diggs, CL. and Chulay, J.D., 1987, Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine, Lancet i (June 6): 1277.Google Scholar
  8. Beatty, J.D., Beatty, B.C, Paraskevas, F. and Froese, E., 1984, Liposomes as immune adjuvants: T cell dependence, Surgery, 96: 345.PubMedGoogle Scholar
  9. Clyde, D.F., McCarthy, V.C, Miller, R.M. and Woodward, W.E., 1975, Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites, Am.J.Trop.Med.Hyg., 24: 397.PubMedGoogle Scholar
  10. Dame, J.B., Williams, J.L., McCutchan, T.F., Weber, J.L., Wirtz, R.A., Hockmeyer, W.T. Maloy, W.L., Haynes, J.D., Schneider, I., Roberts, D., Sanders, G.S., Reddy, E.P., Diggs, C.L. and Miller, L.H., 1984, Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum, Science, 225: 593.PubMedCrossRefGoogle Scholar
  11. Egan, J.E., Weber, J.L., Ballou, W.R., Hollingdale, M.R., Majarian, W.R., Gordon, D.M., Maloy, W.L., Hoffman, S.L., Wirtz, R.A., Schneider, I., Woollett, C.R., Young, J.F. and Hockmeyer, W.T., 1987, Efficacy of murine malaria sporozoite vaccines: Implications for human vaccine development, Science, 236: 453.PubMedCrossRefGoogle Scholar
  12. Fidler, I.J., 1985, Macrophages and metastasis-A biological approach to cancer therapy: Presidential address, Canc.Res., 45: 4714.Google Scholar
  13. Gabizon, A. and Papahad jopoulos, D., 1988, Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors, Proc. Natl. Acad. Sci. U.S.A., 85: 6949.PubMedCrossRefGoogle Scholar
  14. Gregoriadis, G., Kirby, C., Large, P., Meehan, A. and Senior, J., 1982, Targeting of liposomes: Study of influencing factors, in: “Targeting of Drugs”, C Gregoriadis, J. Senior and A. Trouet, eds., Plenum, New York.Google Scholar
  15. Herrington, D.A., Clyde, D.F., Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J., Baqar, S., Felix, A.M., Heimer, E.P., Gillessen, D., Nardin, E., Nussenzweig, R.S., Nussenzweig, V., Hollingdale, M.R. and Levine, M.R., 1987, Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites, Nature, 328: 257.PubMedCrossRefGoogle Scholar
  16. Hoffman, S.L., Wistar, Jr., R., Ballou, W.R., Hollingdale, M.R., Wirtz, R.A., Schneider, I., Marwoto, H.A. and Hockmeyer, W.T., 1986, Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum, New Eng. J. Med., 315: 601.Google Scholar
  17. Hoffman, S.L., Oster, C.N., Plowe, C.V., Woollett, G.R., Beier, J.C., Chulay, J.D., Wirtz, R.A., Hollingdale, M.R. and Mugambi, M., 1987, Naturally acquired antibodies to sporozoites do not prevent malaria: Vaccine development implications, Science, 237: 639PubMedCrossRefGoogle Scholar
  18. Hwarang, K.J., Luk, K.S. and Beaumier, P.L., 1980, Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study, Proc.Natl.Acad.Sci., 77: 4030.CrossRefGoogle Scholar
  19. Nussenzweig, R., Vanderberg, J. and Most, H., 1969, Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. TV. Dose response, specificity and humoral immunity, Milit. Med., 134: 1176.Google Scholar
  20. Papahadjopoulos, D. and Gabizon, A., 1987, Targeting of liposomes to tumor cells in vitro, Ann.N.Y.Acad.Sci., 507: 64.Google Scholar
  21. Potocnjak, P., Yoshida, N., Nussenzweig, R.S. and Nussenzweig, V., 1980, Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection, J.Exp.Med., 151: 1504.PubMedCrossRefGoogle Scholar
  22. Richards, R.L., Hayre, M.D., Hockmeyer, W.T. and Alving, C.R., 1988, Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen, Infect.Immun., 56: 682.PubMedGoogle Scholar
  23. Rieckmann, K.H., Beaudoin, R.L., Cassells, J.S. and Sell, K.W., 1979, Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria, Bull.W.H.O., 57(Suppl. 1): 261.PubMedGoogle Scholar
  24. Shek, P.N. and Lukovich, S., 1982, The role of macrophages in promoting the antibody response mediated by liposome-associated antigens, Immunol. Lett., 5: 305.PubMedCrossRefGoogle Scholar
  25. Steinman, R.M. and Nussenzweig, M.C., 1980, Dendritic cells: Features and functions, Immunol.Rev., 53: 129.CrossRefGoogle Scholar
  26. Swenson, C.E., Popescu, M.C. and Ginsberg, R.S., 1988, Preparation and use of liposomes in the treatment of microbial infections, C.R.C.Crit. Rev.Microbiol., 15(Suppl. 1): 81.Google Scholar
  27. Tew, J.G., Phipps, R.P. and Mandel, T.E., 1980, The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells, Immunol. Rev., 53: 175.PubMedCrossRefGoogle Scholar
  28. Uhanue, E.R., 1984, Antigen-presenting function of the macrophage, Ann. Rev. Immunol., 2: 395.CrossRefGoogle Scholar
  29. Uhanue, E.R. and Allen, P.M., 1987, The basis for the immunoregulatory role of macrophages and other accessory cells, Science, 236: 551.CrossRefGoogle Scholar
  30. Webster, H.K., Boudreau, E.F., Pang, L.W., Permpanich, B., Sookto, P. and Wirtz, R.A., 1987, Development of immunity in natural Plasmodium falciparum malaria: Antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32), J.Clin.Microbiol., 25: 1002.PubMedGoogle Scholar
  31. Wirtz, R.A., Ballou, W.R., Schneider, I., Chedid, L., Gross, M.J., Young, J.F., Hollingdale, M., Diggs, C.L. and Hockmeyer, W.T., 1987, Plasmodium falciparum: Immunogenicity of circumsporozoite protein constructs produced in Escherichia coli, Exp.Parasitol., 63: 166.Google Scholar
  32. Young, J.F., Hockmeyer, W.T., Gross, M., Ballou, W.R., Wirtz, R.A., Trosper, J.H., Beaudoin, R.L., Hollingdale, M.R., Miller, L.H., Diggs, C.L. and Rosenberg, M., 1985, Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine, Science, 228: 958.PubMedCrossRefGoogle Scholar
  33. Zavala, F., Tarn, J.P., Hollingdale, M.R., Cochrane, A.H., Quakyi, I., Nussenzweig, R.S. and Nussenzweig, V., 1985, Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria, Science, 228: 1436.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Carl R. Alving
    • 1
  • Robert L. Richards
    • 1
  • Michael D. Hayre
    • 1
  • Wayne T. Hockmeyer
    • 2
  • Robert A. Wirtz
    • 3
  1. 1.Departments of Membrane BiochemistryWalter Reed Army Institute of ResearchUSA
  2. 2.Departments of ImmunologyWalter Reed Army Institute of ResearchUSA
  3. 3.Departments of EntomologyWalter Reed Army Institute of ResearchUSA

Personalised recommendations